Company
United StatesPAREXEL Early Phase Clinical Unit, Baltimore, MD – FDA Inspections
Inspection records and compliance data for PAREXEL Early Phase Clinical Unit in Baltimore, Maryland. 1 FDA inspection on record, last inspected October 17, 2018.
Company Profile
This profile covers PAREXEL Early Phase Clinical Unit based in Baltimore, Maryland, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected October 17, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 17, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1069420 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
PAREXEL Early Phase Clinical Unit
FEI Number
3005445577
Address
Medstar Harbor Hospital, 3001 S Hanover St Fl 7, Baltimore, Maryland 21225, United States
Country
United States
ID: 9748c7f3-64a9-490d-994d-e02b56d9d1d0